Chongqing Lummy Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Chongqing Lummy Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Chongqing Lummy Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash paid for other financing activities113,129,5700.021891142015-06-30historic
Other current liabilities50,000,0000.009681362015-06-30historic
Goodwill150,522,7220.029131402015-06-30historic
Cash from minority shareholders of subsidiaries1,350,0002.6E-41652015-06-30historic
Construction materials941,5031.8E-41772015-06-30historic
Long term accounts payable15,823,4230.003062182015-06-30historic
Financial expenses31,638,5350.006122982015-06-30historic
Long term borrowings222,943,3400.043143032015-06-30historic
Interest receivable491,6601.0E-43112015-06-30historic
Short term borrowings614,100,0000.118833122015-06-30historic
Diluted eps00.03152015-06-30historic
Investment income from associate and joint venture156,3193.0E-53292015-06-30historic
Cash paid for other investing activities204,1044.0E-53442015-06-30historic
Fixed assets920,162,9870.178053462015-06-30historic
Cash inflows from financing activities682,683,8660.13213862015-06-30historic
Intangible assets143,324,4200.027733952015-06-30historic
Net cashflow from financing activities132,350,4860.025614072015-06-30historic
Total non-current assets1,546,981,1750.299344272015-06-30historic
Cash from other investing activities603,0591.2E-44322015-06-30historic
Selling expenses43,373,3270.008394382015-06-30historic
Deferred tax assets18,153,4140.003514592015-06-30historic
Inventories431,999,7700.083594592015-06-30historic
Total liabilities1,545,500,4450.299064852015-06-30historic
Accounts payable259,840,3150.050284962015-06-30historic
Net change in cash29,330,0210.005685072015-06-30historic
Disposal of fixed assets and others81,8002.0E-55182015-06-30historic
Proceeds from sell of investment1,600,0003.1E-45212015-06-30historic
Interests payable775,1161.5E-45552015-06-30historic
Comprehensive income attributable to minority shareholders113,9412.0E-55742015-06-30historic
Other receivables27,319,2090.005295772015-06-30historic
Minority interests gain113,9412.0E-55832015-06-30historic
Capital reserve543,056,8710.105086052015-06-30historic
Long term equity investment17,109,2160.003316102015-06-30historic
Other payables49,406,3140.009566112015-06-30historic
Minority interest28,629,3360.005546272015-06-30historic
Cash paid for taxes41,551,1670.008046302015-06-30historic
Purchases of fixed assets and others35,160,1340.00686442015-06-30historic
Total liabilities and equity2,554,795,0090.494356462015-06-30historic
Notes receivable12,570,4190.002437002015-06-30historic
Total cost of goods sold430,945,5240.083397482015-06-30historic
Prepayment29,251,0370.005667632015-06-30historic
Other current assets9,646,7480.001877702015-06-30historic
Cash paid for dividends, profits or interests22,685,0700.004397782015-06-30historic
Revenue441,401,7580.085417872015-06-30historic
Cash outflows from operating activities431,778,6640.083558192015-06-30historic
Payroll payable7,144,3550.001388252015-06-30historic
Cash inflows from operating activities428,594,2330.082938262015-06-30historic
Net cash flows from investing activities-99,952,755-0.019348972015-06-30historic
Net cash and cash equivalents ending balance152,194,0720.029459592015-06-30historic
Operating profit10,612,5540.002059912015-06-30historic
Total comprehensive income11,180,2340.0021610162015-06-30historic
Net income11,180,2340.0021610162015-06-30historic
Total profit13,964,6160.002710252015-06-30historic
Non-operating loss61,0521.0E-510742015-06-30historic